These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1434819)

  • 21. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease.
    Blayney DW; Longo DL; Young RC; Greene MH; Hubbard SM; Postal MG; Duffey PL; DeVita VT
    N Engl J Med; 1987 Mar; 316(12):710-4. PubMed ID: 3821809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Second malignancies following treatment in non-Hodgkin's lymphoma.
    Ellis M; Lishner M
    Leuk Lymphoma; 1993 Mar; 9(4-5):337-42. PubMed ID: 8348069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk factors for second acute myeloid leukemia/myelodysplastic syndrome among survivors of non-Hodgkin lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    Leukemia; 2016 May; 30(5):1187-90. PubMed ID: 26369985
    [No Abstract]   [Full Text] [Related]  

  • 24. [Second malignacies complicating Hodgkin's disease. 1 case].
    Blanc AP; Gastaut JA; Carcassonne Y
    Sem Hop; 1979 Jan 8-15; 55(1-2):80-2. PubMed ID: 218300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hodgkin's disease and the risk of acute leukemia in successfully treated patients.
    Valagussa P; Bonadonna G
    Haematologica; 1998 Sep; 83(9):769-70. PubMed ID: 9825571
    [No Abstract]   [Full Text] [Related]  

  • 26. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
    Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
    Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Why is there so much therapy-related AML and MDS and so little therapy-related CML?
    Gale RP; Hlatky L; Sachs RK; Radivoyevitch T
    Leuk Res; 2014 Oct; 38(10):1162-4. PubMed ID: 25175829
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukemia as a second malignancy.
    Uppin MS; Paul TR; Rajappa S; Gayathri K; Jacob R; Uppin SG
    Indian J Pathol Microbiol; 2007 Jul; 50(3):644-7. PubMed ID: 17883171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hodgkin's disease: treatment and secondary neoplasms.
    Kaiser HE
    In Vivo; 1994; 8(5):733-6. PubMed ID: 7727720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myelodysplasias and leukemias after autologous stem cell transplantation for lymphoid malignancies.
    Park S; Brice P; Noguerra ME; Simon D; Rousselot P; Kerneis Y; Morel P; Marolleau JP; Gisselbrecht C
    Bone Marrow Transplant; 2000 Aug; 26(3):321-6. PubMed ID: 10967573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Are myelodysplastic syndromes and acute myeloid leukaemia occurring during the course of lymphoma always therapy related?
    Bigenwald C; Harel S; Chevignon F; Roos-Weil D; Bernard OA; Amorim S; Brice P; Adès L; Nloga AM; Sébert M; Braun T; Eclache V; Thieblemont C; Fenaux P
    Br J Haematol; 2018 Jan; 180(2):304-308. PubMed ID: 27662562
    [No Abstract]   [Full Text] [Related]  

  • 32. [Letter: Secondary neoplasms complicating Hodgkin's disease].
    Focan C; Brictieux N; Lemaire M; Hugues J
    Nouv Presse Med; 1974 May; 3(21):1385. PubMed ID: 4527420
    [No Abstract]   [Full Text] [Related]  

  • 33. [Incidence and significance of therapy-associated late toxicity in Hodgkin's disease].
    Streit M; Thiel E; Kreuser ED
    Dtsch Med Wochenschr; 1995 Aug; 120(31-32):1093-9. PubMed ID: 7641593
    [No Abstract]   [Full Text] [Related]  

  • 34. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary myelodysplastic syndromes and acute leukemias.
    Zeidman A; Dayan DB; Mittelman M
    Haematologia (Budap); 1995; 27(1):23-8. PubMed ID: 12051292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapy-related myelodysplastic syndrome (t-MDS)].
    Yoshida Y
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):206-8. PubMed ID: 9851122
    [No Abstract]   [Full Text] [Related]  

  • 37. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Kröger N; Brand R; van Biezen A; Cahn JY; Slavin S; Blaise D; Sierra J; Zander A; Niederwieser D; de Witte T;
    Bone Marrow Transplant; 2006 Jan; 37(2):183-9. PubMed ID: 16299545
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myelodysplasia and acute leukemia after autologous bone marrow transplantation.
    Armitage JO
    J Clin Oncol; 2000 Mar; 18(5):945-6. PubMed ID: 10694542
    [No Abstract]   [Full Text] [Related]  

  • 39. [Breast cancer after Hodgkin's disease].
    Cutuli B
    J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):301-2. PubMed ID: 8767231
    [No Abstract]   [Full Text] [Related]  

  • 40. Myelodysplastic syndrome in a child with a history of medulloblastoma.
    Akyüz C; Emir S; Güler N; Tüker A; Büyükpamukçu M
    Turk J Pediatr; 1998; 40(1):131-4. PubMed ID: 9673540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.